Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in The Framingham Offspring Study

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 417-424

  Galluzzi, Jennifer R ^a   Cupples, L Adrienne ^b   Otvos, James D ^c   Wilson, Peter W F ^d   Schaefer, Ernst J ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cholesterol; FABP2; Framingham; Polymorphism

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; DNA; ESTROGEN; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN THERAPY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTESTINE CELL; LIPID TRANSPORT; MALE; MENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SEX DIFFERENCE; SMOKING;

AGE DISTRIBUTION; AGED; ALLELES; APOLIPOPROTEINS; CARRIER PROTEINS; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROBABILITY; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 0035202759     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00517-2     Document Type: Article

References (49)

1. The genetic basis of atherosclerosis
2. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans: The San Antonio Heart Study
3. Genetic epidemiology of coronary artery disease
4. Prospective analysis of the insulin-resistance syndrome (Syndrome X)
5. Genetic analysis of the IRS: Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
6. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance
7. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre
8. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene
9. The metabolic significance of mammalian fatty-acid-binding proteins: In search of a function
10. Historic overview on studies on fatty acid-binding proteins
11. Molecular evolution of the multigene family of intracellular lipid-binding proteins
12. Cytoplasmic fatty acid-binding proteins: Their structure and genes
13. Intracellular lipid-binding proteins and their genes
14. Cellular uptake and intracellular trafficking of long chain fatty acids
15. Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine
16. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells
17. Crystal structure of rat intestinal fatty-acid-binding protein. Refinement and analysis of the Escherichia coli-derived protein with bound palmitate
18. Discrete backbone disorder in the nuclear magnetic resonance structure of apo intestinal fatty acid-binding protein: Implications for the mechanism of ligand entry
19. A review of intestinal fatty acid binding protein gene variation and plasma lipoprotein response to dietary components
20. Relation of triglyceride metabolism and coronary artery disease
21. The T 54 allele of the intestinal fatty acid binding protein 2 is associated with a parental history of stroke
22. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia
23. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians
24. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
25. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects
26. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men
27. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects
28. Genetic studies of polymorphisms in ten NIDDM candidate genes in Tamil Indians from Pondichery
29. Lipoprotein-genotype associations in Trinidadian neonates
30. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects
31. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperlipidemia in African-Americans
32. The Framingham Offspring Study. Design and preliminary data
33. An investigation of coronary heart disease in families. The Framingham Offspring Study
34. Long and short-term risk of sudden coronary death
35. The Coronary Primary Prevention Trial: Design and implementation
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
37. Metabolism of apolipoproteins A-I, A-II, and A-IV
38. Enzyme-linked immunosorbent assay for human plasma apolipoprotein
39. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
40. A simple salting out procedure for extracting DNA from human nucleated cells
41. Genotyping method for point mutation detection in the intestinal fatty acid binding protein, using fluorescent probes
42. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism
43. Multipoint quantitative-trait linkage analysis in general pedigrees
44. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy
45. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM
46. Regulation of the biosynthesis of two distinct fatty acid binding proteins in the rat liver and intestine. Influences of sex difference of clofibrate
47. Review of cholesterol absorption with an emphasis on dietary and biliary cholesterol
48. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population
49. Cholesterol absorption: Regulation of cholesterol synthesis and elimination within population variations of serum cholesterol levels